Sarepta Therapeutics, Inc. · NASDAQ:SRPT

BlackRock, Inc. reported a 12.60% stake in Sarepta Therapeutics, Inc. (Schedule 13G/A)

Event Dec 31, 2025 · Filed Jan 21, 2026

BlackRock, Inc. reported a 12.60% stake in Sarepta Therapeutics, Inc., 13,232,652 shares, as a passive investor on Dec 31, 2025. Filed Jan 21, 2026 (Schedule 13G/A).

Stake
12.60%
Shares
13,232,652
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
BlackRock, Inc.12.60%13,232,652

Source

View original at SEC

Related